PubMed

Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood.

Khamly KK, Thursfield VJ, Fay M, Desai J, Toner GC, Choong PF, Ngan SY, Powell GJ, Thomas DM.

Int J Cancer. 2009 Jul 15;125(2):426-31.PMID: 19391136 [PubMed - indexed for MEDLINE]Related articles

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer.

Pezaro C, Rosenthal MA, Gurney H, Davis ID, Underhill C, Boyer MJ, Kotasek D, Solomon B, Toner GC.

Am J Clin Oncol. 2009 Aug;32(4):338-41.PMID: 19363437 [PubMed - indexed for MEDLINE]Related articles

Late relapsing stage I nonseminoma.

Pezaro CJ, Mallesara G, Toner GC.

J Clin Oncol. 2008 Dec 1;26(34):5647-8. Epub 2008 Nov 3. No abstract available. PMID: 18981457 [PubMed - indexed for MEDLINE]Related articles

Clinical relevance of "late" in the management of late relapse after treatment for a germ cell tumor.

Toner GC.

J Clin Oncol. 2008 Dec 1;26(34):5502-3. Epub 2008 Oct 20. No abstract available. PMID: 18936469 [PubMed - indexed for MEDLINE]Related articles

PET for sarcomas other than gastrointestinal stromal tumors.

Toner GC, Hicks RJ.

Oncologist. 2008;13 Suppl 2:22-6. Review.PMID: 18434635 [PubMed - indexed for MEDLINE]Related articlesFree article

Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.

Dawson SJ, Conus NM, Toner GC, Raleigh JM, Hicks RJ, McArthur G, Rischin D.

Anticancer Drugs. 2008 Jun;19(5):547-52.PMID: 18418222 [PubMed - indexed for MEDLINE]Related articles

Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist.

White AJ, LaGerche A, Toner GC, Whitbourn RJ.

Int J Cardiol. 2009 Jan 24;131(3):e92-4. Epub 2007 Oct 24.PMID: 17920711 [PubMed - indexed for MEDLINE]Related articles

The challenge of poor-prognosis germ cell tumors.

Toner GC.

Urol Clin North Am. 2007 May;34(2):187-97; abstract ix. Review.PMID: 17484924 [PubMed - indexed for MEDLINE]Related articles

Phase II study of vinflunine in patients with metastatic renal cell carcinoma.

Goldstein D, Ackland SP, Bell DR, Olver IN, Davis ID, Rosenthal MA, Toner GC, Pinel MC, Byrne M.

Invest New Drugs. 2006 Sep;24(5):429-34.PMID: 16528478 [PubMed - indexed for MEDLINE]Related articles

Clinical applications of molecular imaging in sarcoma evaluation.

Hicks RJ, Toner GC, Choong PF.

Cancer Imaging. 2005 Jun 21;5(1):66-72. Review.PMID: 16154822 [PubMed - indexed for MEDLINE]Related articlesFree article

Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomas.

Nath SV, Prince HM, Choong PF, Toner GC.

Int Semin Surg Oncol. 2005 May 31;2(1):12.PMID: 15927067 [PubMed - as supplied by publisher]Related articlesFree article

Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use.

Toner GC.

J Clin Oncol. 2004 Oct 1;22(19):3842-5. Epub 2004 Aug 9. No abstract available. PMID: 15302908 [PubMed - indexed for MEDLINE]Related articles

Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells.

Prince HM, Simmons PJ, Whitty G, Wall DP, Barber L, Toner GC, Seymour JF, Richardson G, Mrongovius R, Haylock DN.

Br J Haematol. 2004 Aug;126(4):536-45.PMID: 15287947 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor.

Morimoto AM, Tan N, West K, McArthur G, Toner GC, Manning WC, Smolich BD, Cherrington JM.

Oncogene. 2004 Feb 26;23(8):1618-26.PMID: 14985702 [PubMed - indexed for MEDLINE]Related articles

Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humans.

Moss KG, Toner GC, Cherrington JM, Mendel DB, Laird AD.

J Pharmacol Exp Ther. 2003 Nov;307(2):476-80. Epub 2003 Sep 9.PMID: 12966161 [PubMed - indexed for MEDLINE]Related articlesFree article

Poor prognosis germ-cell tumors: An unresolved challenge.

Toner GC, Frydenberg M.

Semin Urol Oncol. 2002 Nov;20(4):251-61. Review.PMID: 12489058 [PubMed - indexed for MEDLINE]Related articles

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.

Rischin D, Ackland SP, Smith J, Garg MB, Clarke S, Millward MJ, Toner GC, Zalcberg J.

Ann Oncol. 2002 Nov;13(11):1810-8.PMID: 12419756 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagus.

Jefford M, Toner GC, Smith JG, Ngan SY, Rischin D, Guiney MJ.

Am J Clin Oncol. 2002 Jun;25(3):277-82.PMID: 12040288 [PubMed - indexed for MEDLINE]Related articles

CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy.

Prince HM, Wall D, Rischin D, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Wolf M, Januszewicz EH, Westerman D, Richardson G, Scarlett J, Briggs P.

Cytotherapy. 2002;4(2):147-55.PMID: 12006210 [PubMed - indexed for MEDLINE]Related articles

Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy.

Prince HM, Bashford J, Wall D, Rischin D, Parker N, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Francis P, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P.

Cytotherapy. 2002;4(2):137-45.PMID: 12006209 [PubMed - indexed for MEDLINE]Related articles

The management of testicular cancer in Victoria, 1988-1993. Urology Study Committee of the Victorian Co-operative Oncology Group.

Toner GC, Neerhut GJ, Schwarz MA, Thursfield VJ, Sandeman TF, Giles GG, Snow RM.

Med J Aust. 2001 Apr 2;174(7):328-31.PMID: 11346104 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

Toner GC, Stockler MR, Boyer MJ, Jones M, Thomson DB, Harvey VJ, Olver IN, Dhillon H, McMullen A, Gebski VJ, Levi JA, Simes RJ.

Lancet. 2001 Mar 10;357(9258):739-45.PMID: 11253966 [PubMed - indexed for MEDLINE]Related articles

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.

Prince HM, Rischin D, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Quinn M, Brettell M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P.

Bone Marrow Transplant. 2000 Nov;26(9):955-61.PMID: 11100274 [PubMed - indexed for MEDLINE]Related articlesFree article

Docetaxel effectively mobilizes peripheral blood CD34+ cells.

Prince HM, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Wall D, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, Brettell M, Rischin D.

Bone Marrow Transplant. 2000 Sep;26(5):483-7.PMID: 11019836 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis.

Rischin D, White MA, Matthews JP, Toner GC, Watty K, Sulkowski AJ, Clarke JL, Buchanan L.

Med J Aust. 2000 Aug 7;173(3):125-7.PMID: 10979376 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic hiccups following chemotherapy.

Gold M, Spruyt O, Toner GC.

J Pain Symptom Manage. 1999 Dec;18(6):387-8. No abstract available. PMID: 10641462 [PubMed - indexed for MEDLINE]Related articles

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

Bishop JF, Dewar J, Toner GC, Smith J, Tattersall MH, Olver IN, Ackland S, Kennedy I, Goldstein D, Gurney H, Walpole E, Levi J, Stephenson J, Canetta R.

J Clin Oncol. 1999 Aug;17(8):2355-64.PMID: 10561297 [PubMed - indexed for MEDLINE]Related articles

A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancer.

Rischin D, Webster LK, Millward MJ, Toner GC, Nawaratne S, Ganju V, Francis P, Bishop JF.

Invest New Drugs. 1999;17(1):73-80.PMID: 10555125 [PubMed - indexed for MEDLINE]Related articles

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors.

Talbot SM, Westerman DA, Grigg AP, Toner GC, Wolf M, Bishop J, McKendrick J, Zalcberg J, Levi J, Fox RM, Green MD.

Ann Oncol. 1999 Aug;10(8):907-14.PMID: 10509151 [PubMed - indexed for MEDLINE]Related articlesFree article

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.

Prince HM, Millward MJ, Rischin D, Blakey D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Seymour JF, Brettell M, Strickland A, Zalcberg J, Richardson G, Scarlett J, Briggs P, Toner GC.

Ann Oncol. 1999 Apr;10(4):479-81.PMID: 10370794 [PubMed - indexed for MEDLINE]Related articlesFree article

Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer.

Prince HM, Gardyn J, Millward MJ, Rischin D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, Brettell M, Toner GC.

Bone Marrow Transplant. 1999 Mar;23(5):427-35.PMID: 10100555 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison.

Toner GC, Shapiro JD, Laidlaw CR, Rischin D, Millward MJ, Wolf M, Januszewicz H, Mitchell SV, Curran AC, Matthews JP, Bishop JF.

J Clin Oncol. 1998 Dec;16(12):3874-9.PMID: 9850033 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of cremophor EL with bolus doxorubicin.

Millward MJ, Webster LK, Rischin D, Stokes KH, Toner GC, Bishop JF, Olver IN, Linahan BM, Linsenmeyer ME, Woodcock DM.

Clin Cancer Res. 1998 Oct;4(10):2321-9.PMID: 9796961 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I study.

Toner GC, Green M, Bishop JF, McKendrick J, Cebon J, Sheridan WP, Lockbaum P, O'Byrne J, Fox RM.

Am J Clin Oncol. 1998 Jun;21(3):263-9.PMID: 9626795 [PubMed - indexed for MEDLINE]Related articles

Poor prognosis germ cell tumors: current status and future directions.

Toner GC, Motzer RJ.

Semin Oncol. 1998 Apr;25(2):194-202. Review. No abstract available. PMID: 9562452 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix.

Tebbutt N, Rischin D, Quinn M, Rome R, Millward MJ, Toner GC, Bishop JF.

Aust N Z J Obstet Gynaecol. 1998 Feb;38(1):87-90.PMID: 9521400 [PubMed - indexed for MEDLINE]Related articles

Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.

Steyerberg EW, Donohue JP, Gerl A, Toner GC, Schraffordt Koops H, Fosså SD, Keizer HJ.

J Urol. 1997 Aug;158(2):474-8. Review.PMID: 9224327 [PubMed - indexed for MEDLINE]Related articles

Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer.

Michael M, Toner GC, Olver IN, Fenessy A, Bishop JF.

Am J Clin Oncol. 1997 Jun;20(3):259-62.PMID: 9167749 [PubMed - indexed for MEDLINE]Related articles

Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy.

Michael M, Bishop JF, Levi JA, Bell DR, Zalcberg JR, Friedlander ML, Olver IN, Smith JG, Toner GC.

Med J Aust. 1997 May 19;166(10):520-3.PMID: 9196484 [PubMed - indexed for MEDLINE]Related articles

Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand.

Bishop JF, Dewar J, Toner GC, Tattersall MH, Olver IN, Ackland S, Kennedy I, Goldstein D, Gurney H, Walpole E, Levi J, Stephenson J.

Oncology (Williston Park). 1997 Apr;11(4 Suppl 3):19-23. Review.PMID: 9144686 [PubMed - indexed for MEDLINE]Related articles

Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer.

Shapiro JD, Millward MJ, Rischin D, Davison JD, Michael M, Francis PA, Ganju V, Toner GC.

Aust N Z J Med. 1997 Feb;27(1):40-4.PMID: 9079252 [PubMed - indexed for MEDLINE]Related articles

Chemotherapy for soft tissue sarcomas. Indications and advances.

Phillips KA, Toner GC.

Acta Orthop Scand Suppl. 1997 Feb;273:133-8. Review. No abstract available. PMID: 9057604 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.

Millward MJ, Zalcberg J, Bishop JF, Webster LK, Zimet A, Rischin D, Toner GC, Laird J, Cosolo W, Urch M, Bruno R, Loret C, James R, Blanc C.

J Clin Oncol. 1997 Feb;15(2):750-8.PMID: 9053501 [PubMed - indexed for MEDLINE]Related articles

Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.

Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD.

Cancer. 1997 Jan 15;79(2):345-55.PMID: 9010108 [PubMed - indexed for MEDLINE]Related articlesFree article

Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel.

Shapiro JD, Millward MJ, Rischin D, Michael M, Walcher V, Francis PA, Toner GC.

Gynecol Oncol. 1996 Oct;63(1):89-93.PMID: 8898175 [PubMed - indexed for MEDLINE]Related articles

Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxel.

Rischin D, Webster LK, Millward MJ, Linahan BM, Toner GC, Woollett AM, Morton CG, Bishop JF.

J Natl Cancer Inst. 1996 Sep 18;88(18):1297-301.PMID: 8797769 [PubMed - indexed for MEDLINE]Related articlesFree article

Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.

Millward MJ, Webster LK, Toner GC, Bishop JF, Rischin D, Stokes KH, Johnston VK, Hicks R.

Aust N Z J Med. 1996 Jun;26(3):372-9.PMID: 8811211 [PubMed - indexed for MEDLINE]Related articles

Paclitaxel (Taxol) as salvage therapy for relapsed ovarian cancer.

Planner RS, Allen DG, Brand AH, Grant PT, Toner GC, Sykes PH.

Aust N Z J Obstet Gynaecol. 1996 May;36(2):168-70.PMID: 8798307 [PubMed - indexed for MEDLINE]Related articles

Association of acquired Pelger-Huet anomaly with taxoid therapy.

Juneja SK, Matthews JP, Luzinat R, Fan Y, Michael M, Rischin D, Millward MJ, Toner GC.

Br J Haematol. 1996 Apr;93(1):139-41.PMID: 8611447 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer.

Millward MJ, Bishop JF, Friedlander M, Levi JA, Goldstein D, Olver IN, Smith JG, Toner GC, Rischin D, Bell DR.

J Clin Oncol. 1996 Jan;14(1):142-8.PMID: 8558189 [PubMed - indexed for MEDLINE]Related articles